DocMorris AG SIX:DOCM:
DOCMORRIS ACCELERATES SEQUENTIAL RX GROWTH AND INCREASES NON-RX REVENUE
DOCMORRIS AG - REVENUE RISES 9.5% IN FIRST NINE MONTHS
DOCMORRIS AG - SEQUENTIAL RX GROWTH ACCELERATES TO 9.2% IN Q3
DOCMORRIS AG - EXTERNAL RX REVENUE UP 37.9% IN NINE MONTHS
DOCMORRIS AG - OUTLOOK 2025: MANAGEMENT CONFIRMS REVENUE AND EARNINGS GUIDANCE FOR 2025 COMMUNICATED ON 10 APRIL
DOCMORRIS AG - DOCMORRIS INCREASED ITS EXTERNAL REVENUE BY 9.5 PER CENT TO CHF 854.3 MILLION IN FIRST NINE MONTHS 2025

